Overall rank by patents
#32,482
of 49,997 tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 13 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B29D (Producing Particular Articles From Plastics OR From Substances IN A Plastic State).
The verdict
According to USPTO PatentsView, Mesnac ranks #32,482 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 13 technology areas.
USPTO PatentsView assignee plate
Corpus R32482 · Foreign Corporation #32,482 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Medizinische UNIVERSITÄT Graz (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Cygnus Biosciences… · near
46 score
Hover · near
46 score
Mesnac · this assignee
46 score
RMH Tech · near
46 score
Source Photonics · near
46 score
3D Lighting… · lowest
7 score
What this shows Mesnac's Innovation Score is 45.7/100 (top 22% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Mesnac Co., Ltd. is a focused PatentsView assignee: 13 CPC subclasses with 37.5% of grants classified under B29D (Producing Particular Articles From Plastics OR From Substances IN A Plastic State). Peak complete grant year is 2022 (4 grants) versus a trough of 1 in 2017. By volume, Mesnac sits between Medizinische UNIVERSITÄT Graz and Metimedi Pharmaceuticals Co., Ltd..
Mesnac Co., Ltd. shows 5 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Medizinische UNIVERSITÄT Graz
8 patents
Mektec Corporation
8 patents
Melitta Professional Coffee Solutions GMBH & Co. KG
8 patents
Meon Medical Solutions GMBH & Co KG
8 patents
Messika Group
8 patents
Meta Intelligence LLC
8 patents
Metarail, Inc.
8 patents
Metimedi Pharmaceuticals Co., Ltd.
8 patents
Mesnac Co., Ltd.
8 patents
What this shows Mesnac holds 8 patents at rank #32,428, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #32,428 in granted patent volume.
Other assignees with the most granted patents in Mesnac's primary technology class.
Two PlainPatent-derived peer sets for Mesnac, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (46 here).
Mesnac's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
46 Top 22% higher than 78% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 12.5% |
| 2018 | 1 | 12.5% |
| 2022 | 4 | 50.0% |
| 2024 | 1 | 12.5% |
| 2025partial year | 1 | 12.5% |
Top 13 of 13 technology areas
Overall rank by patents
#32,482
of 49,997 tracked assignees
45.7 out of 100
What to do with this data
Mesnac Co., Ltd.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.